Arthritis & Rheumatism: Vol 52, No 1

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Related Titles

IssueVolume 77, Issue 7
Pages: 813-940
July 2025

IssueVolume 7, Issue 7
July 2025

Arthritis & Rheumatism

Journal list menu

Tools

Follow journal

Arthritis & Rheumatism: Volume 52, Issue 1

Download PDFs

Editiorial

Rituximab and Wegener's granulomatosis: Are B cells a target in vasculitis treatment?

Editorial

Opioids: To use or not to use? That is the question

Dendritic cells and the shadow line between autoimmunity and disease

Review

How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis

Research Articles

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: Five-year experience from the FIN-RACo trial

C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: Defining subtypes of nonresponse and subsequent response to etanercept

Presentation and analysis of data on radiographic outcome in clinical trials: Experience from the TEMPO study

Evidence that anti–tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended report

Increased CD4+ T cell infiltrates in rheumatoid arthritis–associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis

Responses of lymphocytes of patients with rheumatoid arthritis to IgG modified by oxygen radicals or peroxynitrite

Interleukin-6 receptor shedding is enhanced by interleukin-1β and tumor necrosis factor α and is partially mediated by tumor necrosis factor α–converting enzyme in osteoblast-like cells

Inhibition of interleukin-1β–induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Δ12,14-prostaglandin J2 through a histone deacetylase–independent mechanism

Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project

Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints

Cartilage glycosaminoglycan loss in the acute phase after an anterior cruciate ligament injury: Delayed gadolinium-enhanced magnetic resonance imaging of cartilage and synovial fluid analysis

Role of interleukin-1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilage

Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin-1β

Role of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytes

Use of bone morphogenetic protein 2 and diffusion chambers to engineer cartilage tissue for the repair of defects in articular cartilage

Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene–transduced chondrocytes with adeno-associated virus vector

Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis

Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses

Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations

Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus

Significance of valine/leucine247 polymorphism of β2-glycoprotein I in antiphospholipid syndrome: Increased reactivity of anti–β2-glycoprotein I autoantibodies to the valine247 β2-glycoprotein I variant

Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus

Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression

Antibodies against cyclic citrullinated peptide are associated with HLA–DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis

Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor–negative juvenile idiopathic arthritis in Finnish patients: Haplotype analysis in Finnish families

Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor β1 in cultured normal human fibroblasts

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody–associated vasculitis

A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease

The HLA–B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus–infected patients with slow progression to acquired immunodeficiency syndrome

Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab

Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: The Third National Health and Nutrition Examination Survey

Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: A randomized clinical trial

Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome†

Diagnostic value of sonography in patients with suspected carpal tunnel syndrome: A prospective study

Opioid use by patients in an orthopedics spine clinic

The non–major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage

Reduction of the incidence and severity of collagen-induced arthritis by constitutive Nur77 expression in the T cell lineage

Thrombospondin 1 as an effective gene therapeutic strategy in collagen-induced arthritis

Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library

Concise Communication

Association between stromal cell–derived factor 1 chemokine gene variant and radiographic progression of rheumatoid arthritis

Evidence for two phenotypes in the metabolism of methotrexate to 7-hydroxymethotrexate in patients with rheumatoid arthritis

Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: Evidence for an early onset/disease severity effect

Letters

ILIRN is a prominent genetic regulator of interleukin-1β release

Reply

Programmed death 1 gene polymorphism and systemic lupus erythematosus in different ethnic populations: Comment on the article by Lin et al

Reply

Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor α blockade: Comment on the article by Buch et al

Reply

Fetal first-degree heart block, or where to set the confidence limit: Comment on the article by Sonesson et al

Reply

Childhood myositis assessment scale and muscle strength testing in patients with juvenile dermatomyositis: Comment on the article by Huber et al

Reply

Concerns about the prevalence of primary Sjögren's syndrome: Comment on the article by Theander et al

Reply

Sign up for email alerts

Tools

More from this journal

Related Titles

Inhibition of interleukin-1β–induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Δ^12,14-prostaglandin J₂ through a histone deacetylase–independent mechanism

Significance of valine/leucine²⁴⁷ polymorphism of β₂-glycoprotein I in antiphospholipid syndrome: Increased reactivity of anti–β₂-glycoprotein I autoantibodies to the valine²⁴⁷ β₂-glycoprotein I variant

Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome ^†